Albert-Szent Gyorgyi Medical University of Szeged
43 papers found
Neuronal complex I deficiency occurs throughout the Parkinson’s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage
Glitazone use associated with reduced risk of Parkinson's disease: Glitazone Use and Parkinson's Disease Risk
Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis
Simvastatin is associated with decreased risk of Parkinson disease
No evidence of ischemia in stroke-like lesions of mitochondrial POLG encephalopathy
Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease
Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia: Family History of PD May Affect Progression
Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.
The angiogenic switch leads to a metabolic shift in human glioblastoma.
PNKP Mutations Identified by Whole-Exome Sequencing in a Norwegian Patient with Sporadic Ataxia and Edema
ADCK3mutations with epilepsy, stroke-like episodes and ataxia: a POLG mimic?
Mitochondrial DNA homeostasis is essential for nigrostriatal integrity
Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy
Nigrostriatal denervationsineparkinsonism: Table 1
Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromes
A man in his 50s with high ferritin levels and increasing cognitive impairment.
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement
HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia
Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report
En kvinne i 70-årene med langvarige gangvansker
Missing publications? Search for publications with a matching author name.